The most intensive medical obesity therapy in the pipeline is retatrutide. Retatrutide is the "triple G," a glucose dependent insulinotropic polypeptide (GIP), glucagon like peptide 1 (GLP 1), and glucagon receptor agonist. It has demonstrated robust blood Umbrella Labs Cagrilintide Peptide Research Use Only Program Expands Laboratory Access For High Rigor Amylin Receptor, Calcitonin Receptor, And Neuroendocrine Signaling Bench Science CagriSema (Cagrilintide + Semaglutide) and Retatrutide are highly effective for weight loss, but differ in mechanisms. CagriSema combines amylin and GLP 1 effects, enhancing appetite suppression and Semaglutide vs Tirzepatide, Cagrilintide, and Retatrutide: Mechanisms & Research Insights